SCHEMBL6601536

SCHEMBL6601536

CC(=O)N(c1ccccc1)C1CCCCC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.64
▸ NPC1 O15118 2/20 0.64
▸ ALDH1A1 P00352 2/20 0.64
▸ RAB9A P51151 2/20 0.64
▸ PAX8 Q06710 2/20 0.64
▸ MEN1 O00255 1/20 0.64
▸ MITF O75030 1/20 0.64
▸ KMT2A Q03164 1/20 0.64
▸ SMN1; SMN2 Q16637 1/20 0.64
▸ LMNA P02545 1/20 0.61
▸ TRPM8 Q7Z2W7 5/20 0.59
▸ L3MBTL1 Q9Y468 3/20 0.55
▸ PKM P14618 2/20 0.55
▸ SPHK1 Q9NYA1 2/20 0.55
▸ APAF1 O14727 1/20 0.55
▸ TDP2 O95551 1/20 0.55
▸ S1PR4 O95977 1/20 0.55
▸ HSP90AA1 P07900 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ XBP1 P17861 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8807231 0.91 CHRM3 (0.54) KDM4ENPC1ALDH1A1RAB9APAX8
SCHEMBL9256458 0.88 LMNA (0.55) KDM4ENPC1ALDH1A1RAB9APAX8
SCHEMBL27981323 0.86 LMNA (0.51) KDM4ENPC1ALDH1A1RAB9APAX8
SCHEMBL6215102 0.85 KDM4E (0.68) KDM4ENPC1ALDH1A1RAB9APAX8
SCHEMBL13681469 0.84 OPRD1 (0.49) KDM4ENPC1ALDH1A1RAB9APAX8
SCHEMBL9776407 0.84 LMNA (0.51) KDM4ENPC1ALDH1A1RAB9APAX8
SCHEMBL8920546 0.84 LMNA (0.55) KDM4ENPC1ALDH1A1RAB9APAX8
SCHEMBL2395969 0.84 ALDH1A1 (0.66) KDM4ENPC1ALDH1A1RAB9APAX8
SCHEMBL31425727 0.83 KDM4E (0.57) KDM4ENPC1ALDH1A1RAB9APAX8
SCHEMBL11407980 0.83 MEN1 (0.65) KDM4ENPC1ALDH1A1RAB9APAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377283-A2 COMPOUNDS OF THE FORMULA R1-X-Y-Z-NR2R3 AS ABCA-1 ELEVATING AGENTS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS CV THERAPEUTICS, INC. (US) 2004-01-07 — — EP claimed
WO-2002046141-A2 COUMPOUNDS OF THE FORMULA R1-X-Y-Z-NR2R3 AS ABCA-1 ELEVATING AGENTS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS CV THERAPEUTICS, INC. (US) 2002-06-13 — — WO claimed
EP-1377283-A2 COMPOUNDS OF THE FORMULA R1-X-Y-Z-NR2R3 AS ABCA-1 ELEVATING AGENTS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS CV THERAPEUTICS, INC. (US) 2004-01-07 — — EP disclosed
WO-2003103651-A1 COMPOUNDS OF THE FORMU;A R1-X-Y-Z-NR2R3 AS ABCA-1 ELEVATING AGENTS AGAINST CAD OR ATHEROSCLEROSIS CV THERAPEUTICS, INC. (US) 2003-12-18 — — WO disclosed
WO-2002046141-A2 COUMPOUNDS OF THE FORMULA R1-X-Y-Z-NR2R3 AS ABCA-1 ELEVATING AGENTS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS CV THERAPEUTICS, INC. (US) 2002-06-13 — — WO disclosed
Send feedback